Results 101 to 110 of about 3,222 (233)
Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G +4 more
doaj
Objective: Several studies have demonstrated the beneficial role of antiplatelet therapy with acetylsalicylic acid (ASA) at atherosclerotic vascular disease. Antiaggregant effect of ASA is not uniform in all patients.
Ornek, Ender +8 more
core +1 more source
Platelet adhesion, aggregation, secretion, and survival have been shown to be changed in atherosclerosis disease and thromboembolic phenomena thus further increasing interest on antiaggregant drugs.
Weber, G. +4 more
core +1 more source
Evaluation of the bleeding risk for patients who have used Clopidogrel or Ticagrelor: the aggregation of platelets and FERMT3 gene's polymorphism investigations. [PDF]
Antiaggregants have been imposed for the patients with cardiovascular diseases after stent’s implantation operations. Antiaggregants do not often cause the expected effect of drugs.
Jurgaitytė, Julija
core

